General News | Mar. 25, 2015

People With Lupus Must Have Access to Prescription Drugs

People with lupus need and deserve a full arsenal of treatments. With many new and innovative drugs for lupus in the drug pipeline, these highly anticipated treatments will mean nothing if people with lupus cannot afford them.

Research News | Mar. 16, 2015

Foundation-Funded Study Identifies Lupus Related Gene that Affects Adult Stem Cells

A new research study by Foundation grantee Dr. Laurence Morel identifies a lupus related gene that affects adult mesenchymal stem cells. Read more.

Research News | Mar. 13, 2015

Corticosteroid Use and Lupus

Part of a new analysis from the ongoing Hopkins Lupus Cohort provides new knowledge that may help physicians make decisions about gradually reducing corticosteroid doses in people with lupus.

Blog | Feb. 17, 2015

An Update on Recent Hydroxychloroquine Shortages

When the Lupus Foundation of America became aware of a hydroxychloroquine (Plaquenil®) shortage, we set out to discover the root of problem. While we still have limited information, we want to alert our constituents to the facts of the situation.

Research News | Feb. 03, 2015

Symposium Sheds Light on Clinical Trials

At a scientific symposium in San Francisco last month, some of the country’s foremost experts on lupus shared their insights about the current state of lupus clinical trial design. Read more.

General News | Jan. 15, 2015

Lupus Organizations Collaborate to Further Advance Lupus Research

The request for nominations for the Lupus Insight Prize will open January 15, 2015 and will be awarded at the Federation of Clinical Immunology Societies (FOCIS) annual meeting in San Diego this June.

Blog | Nov. 17, 2014

American College of Rheumatology Annual Meeting 2014 – Day 2

Today’s sessions will focus on pediatric lupus and biomarkers, including a Foundation-funded research program about pediatric lupus in South Africa. Learn more!

General News | Nov. 15, 2014

Lupus Research Studies Widen Understanding

Foundation-funded research studies highlighted at premier rheumatology meeting in Boston.